JULIA SHULMAN, MD
Ophthalmology Physician · NEW YORK, NY
Individual Active NPI 1649464835
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 307 | 6,947 | $3,925,361 | $808,120 | $633,601 |
| 2023 | 334 | 3,098 | $2,724,997 | $643,456 | $500,180 |
| 2022 | 304 | 2,669 | $2,302,662 | $544,554 | $423,753 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 3,120 | $35 | $28 |
| J0177 | Injection, aflibercept hd, 1 mg | 816 | $332 | $265 |
| 92134 | Imaging of retina | 703 | $45 | $35 |
| 92014 | Established patient complete exam of visual system | 507 | $144 | $104 |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 412 | $17 | $13 |
| 67028 | Injection of drug into eye | 305 | $135 | $101 |
| J0178 | Injection, aflibercept, 1 mg | 182 | $836 | $665 |
| 92273 | Measurement of retinal and optic nerve function | 114 | $145 | $113 |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 64 | $187 | $139 |
| J9035 | Injection, bevacizumab, 10 mg | 51 | $72 | $57 |
| 92004 | New patient complete exam of visual system | 33 | $170 | $126 |
| 76512 | 2d ultrasound scan of eye tissue and structures | 24 | $61 | $47 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 245828 | NY |
| Ophthalmology Physician | 207W00000X | ME 112907 | FL | |
| Ophthalmology Physician | 207W00000X | ME112907 | FL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in New York
- NPI 1578976973
- NPI 1427639897
- NPI 1013394360
- NPI 1982655981
- NPI 1457931974
- NPI 1952397614
- NPI 1407024482
- NPI 1336454495
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.